Intensive insulin therapy in the intensive cardiac care unit

References

• Suleiman M., Hammerman H., Boulos M., Kapeliovich M. R., Suleiman A., Agmon Y., et al. Fasting glucose is an important independent risk factor for 30‐day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111: 754–60
   PubMed Web of Science ®Google Scholar
• Capes S. E., Hunt D., Malmberg K., Gerstein H. C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773–8
   PubMed Web of Science ®Google Scholar
• Whitcomb B. W., Pradhan E. K., Pittas A. G., Roghmann M. C., Perencevich E. N. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 2005; 33: 2772–7
   PubMed Web of Science ®Google Scholar
• Norhammar A., Tenerz A., Nilsson G., Hamsten A., Efendic S., Ryden L., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140–4
   PubMed Web of Science ®Google Scholar
• Clement S., Braithwaite S. S., Magee M. F., Ahmann A., Smith E. P., Schafer R. G., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27: 553–91
   PubMed Web of Science ®Google Scholar
• Cinar Y., Senyol A. M., Duman K. Blood viscosity and blood pressure: role of temperature and hyperglycemia. Am J Hypertens 2001; 14: 433–8
   PubMed Web of Science ®Google Scholar
• Pandolfi A., Giaccari A., Cilli C., Alberta M. M., Morviducci L., De Filippis E. A., et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol 2001; 38: 71–6
   PubMed Web of Science ®Google Scholar
• Davi G., Catalano I., Averna M., Notarbartolo A., Strano A., Ciabattoni G., et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990; 322: 1769–74
   PubMed Web of Science ®Google Scholar
• Gresele P., Guglielmini G., De Angelis M., Ciferri S., Ciofetta M., Falcinelli E., et al. Acute, short‐term hyperglycemia enhances shear stress‐induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 2003; 41: 1013–20
   PubMed Web of Science ®Google Scholar
• Marfella R., Nappo F., De Angelis L., Siniscalchi M., Rossi F., Giugliano D. The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 2000; 43: 571–5
   PubMed Web of Science ®Google Scholar
• Title L. M., Cummings P. M., Giddens K., Nassar B. A. Oral glucose loading acutely attenuates endothelium‐dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J Am Coll Cardiol 2000; 36: 2185–91
   PubMed Web of Science ®Google Scholar
• Williams S. B., Goldfine A. B., Timimi F. K., Ting H. H., Roddy M. A., Simonson D. C., et al. Acute hyperglycemia attenuates endothelium‐dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695–701
   PubMed Web of Science ®Google Scholar
• Kersten J. R., Schmeling T. J., Orth K. G., Pagel P. S., Warltier D. C. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol 1998; 275: H721–5
   Google Scholar
• Kersten J. R., Toller W. G., Tessmer J. P., Pagel P. S., Warltier D. C. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide‐mediated mechanism. Am J Physiol Heart Circ Physiol 2001; 281: H2097–104
   Web of Science ®Google Scholar
• Ceriello A., Quagliaro L., D'Amico M., Di Filippo C., Marfella R., Nappo F., et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002; 51: 1076–82
   PubMed Web of Science ®Google Scholar
• Verma S., Maitland A., Weisel R. D., Li S. H., Fedak P. W., Pomroy N. C., et al. Hyperglycemia exaggerates ischemia‐reperfusion‐induced cardiomyocyte injury: reversal with endothelin antagonism. J Thorac Cardiovasc Surg 2002; 123: 1120–4
   PubMed Web of Science ®Google Scholar
• Opie L. H. The glucose hypothesis: Relation to acute myocardial ischaemia. J Mol Cell Cardiol 1970; 1: 107–15
   Google Scholar
• Oliver M. F., Opie L. H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994; 343: 155–8
   PubMed Web of Science ®Google Scholar
• Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106: 2067–72
   PubMed Web of Science ®Google Scholar
• Sodi‐Pallares D., Ponce dL., Bisteni A., Medrano G. A. Potassium, glucose, and insulin in myocardial infarction. Lancet 1969; 1: 1315–6
   PubMedGoogle Scholar
• Fath‐Ordoubadi F., Beatt K. J. Glucose‐insulin‐potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo‐controlled trials. Circulation 1997; 96: 1152–6
   PubMed Web of Science ®Google Scholar
• Diaz R., Paolasso E. A., Piegas L. S., Tajer C. D., Moreno M. G., Corvalan R., et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998; 98: 2227–34
   PubMed Web of Science ®Google Scholar
• Krljanac G., Vasiljevic Z., Radovanovic M., Stankovic G., Milic N., Stefanovic B., et al. Effects of glucose‐insulin‐potassium infusion on ST‐elevation myocardial infarction in patients treated with thrombolytic therapy. Am J Cardiol 2005; 96: 1053–8
   PubMedGoogle Scholar
• Van der Horst I., De Luca G., Ottervanger J. P., de Boer M. J., Hoorntje J. C., Suryapranata H., Dambrink J. H., et al. ST‐segment elevation resolution and outcome in patients treated with primary angioplasty and glucose‐insulin‐potassium infusion. Am Heart J 2005; 149: 1135
   PubMed Web of Science ®Google Scholar
• Van der Horst I. C. C., Zijlstra F., van't Hof A. W. J., Doggen C. J. M., de Boer M. J., Suryapranata H., et al. Glucose‐insulin‐potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: The glucose‐insulin‐potassium study: a randomized trial. J Am Coll Cardiol 2003; 42: 784–91
   PubMedGoogle Scholar
• Apstein C. S. The benefits of glucose‐insulin‐potassium for acute myocardial infarction (and some concerns). J Am Coll Cardiol 2003; 42: 792–5
   PubMedGoogle Scholar
• Mehta S. R., Yusuf S., Diaz R., Zhu J., Pais P., Xavier D., et al. Effect of glucose‐insulin‐potassium infusion on mortality in patients with acute ST‐segment elevation myocardial infarction: the CREATE‐ECLA randomized controlled trial. JAMA 2005; 293: 437–46
   PubMed Web of Science ®Google Scholar
• Taegtmeyer H. No Benefit of GIK in Acute MI? Time Will Tell!. Curr Hypertens Rep 2005; 7((6))397–398
   Web of Science ®Google Scholar
• Van den B. G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359–67
   PubMed Web of Science ®Google Scholar
• Lazar H. L., Chipkin S. R., Fitzgerald C. A., Bao Y., Cabral H., Apstein C. S. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109: 1497–502
   PubMed Web of Science ®Google Scholar
• Krinsley J. S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992–1000
   PubMed Web of Science ®Google Scholar
• Van den B. G., Wilmer A., Hermans G., Meersseman W., Wouters P. J., Milants I., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449–61
   PubMed Web of Science ®Google Scholar
• Prevalence of Hyperglycemia in VA Intensive Care Unit (ICU) Patients 1996–2005: American Diabetes Association 66th Scientific Sessions, 2006
   Google Scholar
• Stefanidis A., Melidonis A., Tournis S., Zairis M., Handanis S., Olympios C., et al. Intensive insulin treatment reduces transient ischaemic episodes during acute coronary events in diabetic patients. Acta Cardiol 2002; 57: 357–64
   PubMed Web of Science ®Google Scholar
• Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997; 314: 1512–5
   PubMed Web of Science ®Google Scholar
• Malmberg K., Ryden L., Efendic S., Herlitz J., Nicol P., Waldenstrom A., et al. Randomized trial of insulin‐glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57–65
   PubMed Web of Science ®Google Scholar
• Malmberg K., Ryden L., Wedel H., Birkeland K., Bootsma A., Dickstein K., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26: 650–61
   PubMed Web of Science ®Google Scholar
• Yusuf S. Intensive insulin‐glucose infusion regimens with long‐term or standard glucose control did not differ for reducing mortality in type 2 diabetes mellitus and MI. ACP J Club 2005; 143: 43
   PubMedGoogle Scholar
• Van der Horst I., Zijlstra F. Role for insulin in acute myocardial infarction: ruled out or hard to prove?. Eur Heart J 2005; 26: 2600
   PubMedGoogle Scholar
• Finney S. J., Zekveld C., Elia A., Evans T. W. Glucose control and mortality in critically ill patients. JAMA 2003; 290: 2041–7
   PubMed Web of Science ®Google Scholar